Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Plant extracts may help treat hormone-related hair loss.

Dutasteride may help reduce brain inflammation and improve cognition.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

New oral treatment, finasteride, effectively and safely treats common hair loss.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.